Phat Le, MD

Articles by Phat Le, MD

Dr. Le on Research Needed to Address Unmet Needs in mCRC

ByPhat Le, MD

May 26th 2020

Phat Le, MD, discusses research efforts that are needed to address unmet needs in metastatic colorectal cancer.

Dr. Le on the Need for Aggressive Treatment Interventions in Oligometastatic CRC

ByPhat Le, MD

March 24th 2020

Phat Le, MD, discusses the need for aggressive therapeutic approaches in oligometastatic colorectal cancer.

Dr. Le on Treatment Approaches for Oligometastatic Colorectal Cancer

ByPhat Le, MD

March 18th 2020

Phat Le, MD, assistant professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses treatment approaches for patients with oligometastatic colorectal cancer (CRC).

Latest Updated Articles

Dr. Le on Treatment Approaches for Oligometastatic Colorectal Cancer
March 18th 2020
Dr. Le on the Need for Aggressive Treatment Interventions in Oligometastatic CRC
March 24th 2020
Dr. Le on Research Needed to Address Unmet Needs in mCRC
May 26th 2020

Phat Le, MD

Articles by Phat Le, MD

Dr. Le on Research Needed to Address Unmet Needs in mCRC

Dr. Le on the Need for Aggressive Treatment Interventions in Oligometastatic CRC

Dr. Le on Treatment Approaches for Oligometastatic Colorectal Cancer

Latest Updated Articles

Trending on OncLive

FDA Accepts Third RP1 BLA Resubmission With Nivolumab in Advanced Melanoma

From "Not Curable" to "May Be Curable": Joshua Richter, MD, on the New Reality of Multiple Myeloma

MAIC Shows OS Benefit With Mogamulizumab vs Vorinostat in Cutaneous T-Cell Lymphoma Subtypes

Analysis Identifies Potential Response, Resistance Biomarkers to Mogamulizumab in R/R Mycosis Fungoides/Sézary Syndrome

Revised Risk Stratifications Help Inform the Use of Adjuvant Cemiplimab and Neoadjuvant Strategies in Cutaneous Squamous Cell Carcinoma